# Celularity Inc: Form 8-K, filed Jul 22, 2021

- Company: [Celularity Inc](/companies/celu.md) (CIK 1752828)
- Form: 8-K
- Filed: 2021-07-22
- Accepted by EDGAR: Jul 22, 2021, 16:13 ET
- Period: 2021-07-16
- Accession: 0001213900-21-038102
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1752828/000121390021038102/ea144415-8k_celularityinc.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1752828/000121390021038102/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 4.01: Change of auditor
- Item 5.01: Change in control
- Item 5.02: Departure or appointment of officers or directors
- Item 5.06: Item not in the standard list
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1752828/000121390021038102/ea144415-8k_celularityinc.htm

Filed Jul 22, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-038102. Last ingested by Listed: Nov 11, 2026, 02:51 ET. No prices; not investment advice.
